In an opinion published recently in Annals of Internal Medicine, I2DB Director Dr. Philip Payne and co-authors outlined timely AI considerations for health systems, recommending robust structural foundations and clinician engagement, as well as strategic outcome measurement to improve care quality, mitigate AI-related risks, and address social equity. They emphasized that AI should be viewed as a strategic investment and that accountability, interdisciplinary governance, and intersectional leadership are highly important in the AI space. Read the opinion to learn more.
Opinion: Meeting the Artificial Intelligence Needs of U.S. Health Systems
